BMY insider transaction filings
BRISTOL MYERS SQUIBB CO — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-10. Screen BMY transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 10 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings by 2 insiders — 6,749 shares, $437,248 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 6,249 shares @ $64.57 ($403,498) by Massacesi Cristian, filed 2026-09-10.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Massacesi Cristian — EVP,Chief Med Offr,Head of Dev | 2 | — | 1 leg · 6,249 sh · $403,498 | 3 |
| Holzer Phil M — SVP and Controller | 1 | — | 1 leg · 500 sh · $33,750 | — |
| Gallman Cari — EVP, General Counsel | 1 | — | — | 3 |
| Short Bartie Wendy — EVP, Corporate Affairs | 1 | — | — | 3 |
| Arduini Peter J — Director | 1 | — | — | 1 |
| McMullen Michael R. — Director | 1 | — | — | 1 |
| Rice Derica W — Director | 1 | — | — | 1 |
| Samuels Theodore R. II — Director | 1 | — | — | 1 |
| YALE PHYLLIS R — Director | 1 | — | — | 1 |
Recent Form 4 filings — BRISTOL MYERS SQUIBB CO
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-10 | 4 | Massacesi Cristian — EVP,Chief Med Offr,Head of Dev | Sale (S): 6,249 @ $64.57 | EDGAR |
| 2026-09-03 | 4 | Short Bartie Wendy — EVP, Corporate Affairs | Option exercise (M): 1,236 @ $66.92 · Tax withholding (F): 633 @ $66.92 · Option exercise (M): 1,236 (derivative) @ $0 | EDGAR |
| 2026-08-26 | 4 | Holzer Phil M — SVP and Controller | Sale (S): 500 @ $67.50 | EDGAR |
| 2026-08-04 | 4 | Massacesi Cristian — EVP,Chief Med Offr,Head of Dev | Option exercise (M): 51,172 @ $0 · Tax withholding (F): 26,175 @ $65.31 · Option exercise (M): 51,172 (derivative) @ $0 | EDGAR |
| 2026-08-04 | 4 | Gallman Cari — EVP, General Counsel | Option exercise (M): 1,061 @ $0 · Tax withholding (F): 543 @ $65.31 · Option exercise (M): 1,061 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Samuels Theodore R. II — Director | Grant/award (A): 889.45 (derivative) @ $57.62 | EDGAR |
| 2026-07-02 | 4 | McMullen Michael R. — Director | Grant/award (A): 607.43 (derivative) @ $57.62 | EDGAR |
| 2026-07-02 | 4 | Rice Derica W — Director | Grant/award (A): 672.51 (derivative) @ $57.62 | EDGAR |
| 2026-07-02 | 4 | Arduini Peter J — Director | Grant/award (A): 607.43 (derivative) @ $57.62 | EDGAR |
| 2026-07-02 | 4 | YALE PHYLLIS R — Director | Grant/award (A): 607.43 (derivative) @ $57.62 | EDGAR |
| 2026-06-16 | 4 | Haller Julia A — Director | Option exercise (M): 20,460 @ $53.76 · Option exercise (M): 20,460 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Short Bartie Wendy — EVP, Corporate Affairs | Option exercise (M): 8,040 @ $0 · Tax withholding (F): 3,876 @ $54.72 · Option exercise (M): 8,040 (derivative) @ $0 | EDGAR |
| 2026-05-05 | 4 | Lenkowsky Adam — EVP, Chief Commercial Officer | Option exercise (M): 1,373 @ $0 · Other (J): 203 @ $0 · Tax withholding (F): 599 @ $58.22 · Option exercise (M): 1,373 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | Shanahan Karin — EVP, Chief Supply Chain & Ops | Option exercise (M): 3,307 @ $0 · Tax withholding (F): 1,692 @ $61.73 · Option exercise (M): 3,307 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | Samuels Theodore R. II — Director | Grant/award (A): 845.01 (derivative) @ $60.65 | EDGAR |
| 2026-04-02 | 4 | Elkins David V — EVP, Chief Financial Officer | Sale (S): 25,519 @ $61.60 · Sale (S): 4,481 @ $62.05 | EDGAR |
| 2026-04-02 | 4 | McMullen Michael R. — Director | Grant/award (A): 577.08 (derivative) @ $60.65 | EDGAR |
| 2026-04-02 | 4 | Rice Derica W — Director | Grant/award (A): 638.91 (derivative) @ $60.65 | EDGAR |
| 2026-04-02 | 4 | Arduini Peter J — Director | Grant/award (A): 577.08 (derivative) @ $60.65 | EDGAR |
| 2026-04-02 | 4 | YALE PHYLLIS R — Director | Grant/award (A): 577.08 (derivative) @ $60.65 | EDGAR |
| 2026-03-12 | 4 | Massacesi Cristian — EVP,Chief Med Offr,Head of Dev | Grant/award (A): 26,122 (derivative) @ $0 · Grant/award (A): 39,184 (derivative) @ $0 | EDGAR |
| 2026-03-12 | 4 | Shibutani Hiroshi Chris — EVP, Chief Strategy Officer | Grant/award (A): 7,837 (derivative) @ $0 · Grant/award (A): 11,755 (derivative) @ $0 | EDGAR |
| 2026-03-12 | 4 | Short Bartie Wendy — EVP, Corporate Affairs | Option exercise (M): 639 @ $0 · Other (J): 72 @ $0 · Tax withholding (F): 205 @ $60.13 · Option exercise (M): 749 @ $0 · Other (J): 81 @ $0 · Tax withholding (F): 242 @ $60.13 · +8 more | EDGAR |
| 2026-03-12 | 4 | Holzer Phil M — SVP and Controller | Option exercise (M): 811 @ $0 · Other (J): 91 @ $0 · Tax withholding (F): 261 @ $60.13 · Option exercise (M): 768 @ $0 · Other (J): 83 @ $0 · Tax withholding (F): 248 @ $60.13 · +8 more | EDGAR |
| 2026-03-12 | 4 | Hoch Lynelle — President, Cell Therapy Org. | Option exercise (M): 838 @ $0 · Other (J): 94 @ $0 · Tax withholding (F): 212 @ $60.13 · Option exercise (M): 1,050 @ $0 · Other (J): 113 @ $0 · Tax withholding (F): 267 @ $60.13 · +8 more | EDGAR |
| 2026-03-12 | 4 | Poole Ahn Amanda — EVP, Chief People Officer | Option exercise (M): 811 @ $0 · Other (J): 91 @ $0 · Tax withholding (F): 369 @ $60.13 · Option exercise (M): 803 @ $0 · Other (J): 87 @ $0 · Tax withholding (F): 367 @ $60.13 · +8 more | EDGAR |
| 2026-03-12 | 4 | Gallman Cari — EVP, General Counsel | Option exercise (M): 912 @ $0 · Other (J): 102 @ $0 · Tax withholding (F): 415 @ $60.13 · Option exercise (M): 867 @ $0 · Other (J): 94 @ $0 · Tax withholding (F): 396 @ $60.13 · +8 more | EDGAR |
| 2026-03-12 | 4 | Lenkowsky Adam — EVP, Chief Commercial Officer | Option exercise (M): 1,828 @ $0 · Other (J): 205 @ $0 · Tax withholding (F): 831 @ $60.13 · Option exercise (M): 2,000 @ $0 · Other (J): 216 @ $0 · Tax withholding (F): 913 @ $60.13 · +12 more | EDGAR |
| 2026-03-12 | 4 | Shanahan Karin — EVP, Chief Supply Chain & Ops | Option exercise (M): 2,448 @ $0 · Other (J): 275 @ $0 · Tax withholding (F): 1,112 @ $60.13 · Option exercise (M): 3,293 @ $0 · Other (J): 356 @ $0 · Tax withholding (F): 1,503 @ $60.13 · +8 more | EDGAR |
| 2026-03-12 | 4 | Meyers Gregory Scott — EVP, Chief Digital & Tech Off. | Option exercise (M): 2,839 @ $0 · Other (J): 319 @ $0 · Tax withholding (F): 1,069 @ $60.13 · Option exercise (M): 3,293 @ $0 · Other (J): 356 @ $0 · Tax withholding (F): 1,246 @ $60.13 · +8 more | EDGAR |
| 2026-03-12 | 4 | Plenge Robert M — EVP, Chief Research Officer | Option exercise (M): 1,107 @ $0 · Other (J): 124 @ $0 · Tax withholding (F): 436 @ $60.13 · Option exercise (M): 2,342 @ $0 · Other (J): 253 @ $0 · Tax withholding (F): 927 @ $60.13 · +8 more | EDGAR |
| 2026-03-12 | 4 | Hickey Benjamin — President, RayzeBio Org. | Grant/award (A): 11,429 (derivative) @ $0 · Grant/award (A): 17,143 (derivative) @ $0 | EDGAR |
| 2026-03-12 | 4 | BOERNER CHRISTOPHER S. — Chief Executive Officer, Director | Option exercise (M): 6,618 @ $0 · Other (J): 743 @ $0 · Tax withholding (F): 3,006 @ $60.13 · Option exercise (M): 6,733 @ $0 · Other (J): 727 @ $0 · Tax withholding (F): 3,073 @ $60.13 · +12 more | EDGAR |
| 2026-03-12 | 4 | Elkins David V — EVP, Chief Financial Officer | Option exercise (M): 7,654 @ $0 · Other (J): 860 @ $0 · Tax withholding (F): 2,883 @ $60.13 · Option exercise (M): 7,904 @ $0 · Other (J): 854 @ $0 · Tax withholding (F): 2,991 @ $60.13 · +8 more | EDGAR |
| 2026-03-03 | 4 | Hickey Benjamin — President, RayzeBio Org. | Option exercise (M): 3,286 @ $0 · Tax withholding (F): 1,672 @ $62.37 · Option exercise (M): 3,286 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Bhatt Deepak — Director | Grant/award (A): 3,996.37 (derivative) @ $55.05 | EDGAR |
| 2026-02-03 | 4 | Meyers Gregory Scott — EVP, Chief Digital & Tech Off. | Option exercise (M): 2,543 @ $0 · Tax withholding (F): 833 @ $55.05 · Option exercise (M): 2,543 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Hidalgo Medina Manuel — Director | Grant/award (A): 3,996.37 (derivative) @ $55.05 | EDGAR |
| 2026-02-03 | 4 | Hickey Benjamin — President, RayzeBio Org. | Option exercise (M): 10,079 @ $0 · Tax withholding (F): 3,810 @ $55.05 · Option exercise (M): 10,079 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Vousden Karen H — Director | Grant/award (A): 3,996.37 (derivative) @ $55.05 | EDGAR |
| 2026-02-03 | 4 | Samuels Theodore R. II — Director | Grant/award (A): 3,996.37 (derivative) @ $55.05 | EDGAR |
| 2026-02-03 | 4 | Haller Julia A — Director | Grant/award (A): 3,996.37 (derivative) @ $55.05 | EDGAR |
| 2026-02-03 | 4 | McMullen Michael R. — Director | Grant/award (A): 3,996.37 (derivative) @ $55.05 | EDGAR |
| 2026-02-03 | 4 | Price Paula A — Director | Grant/award (A): 3,996.37 (derivative) @ $55.05 | EDGAR |
| 2026-02-03 | 4 | Rice Derica W — Director | Grant/award (A): 3,996.37 (derivative) @ $55.05 | EDGAR |
| 2026-02-03 | 4 | Arduini Peter J — Director | Grant/award (A): 3,996.37 (derivative) @ $55.05 | EDGAR |
| 2026-02-03 | 4 | YALE PHYLLIS R — Director | Grant/award (A): 3,996.37 (derivative) @ $55.05 | EDGAR |
| 2026-01-05 | 4 | Rice Derica W — Director | Grant/award (A): 695.22 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Arduini Peter J — Director | Grant/award (A): 625.70 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | YALE PHYLLIS R — Director | Grant/award (A): 648.87 (derivative) @ $0 | EDGAR |
Recent 8-K events — BRISTOL MYERS SQUIBB CO
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-30 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-08 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-04-30 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-05 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-18 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-10 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-03 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-30 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-31 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BMY returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →